Filtered By:
Infectious Disease: Hepatitis B
This page shows you your search results in order of date. This is page number 17.
Order by Relevance | Date
Total 12613 results found since Jan 2013.
Screening for hepatitis B: Where the CDC and USPSTF diverge
J Fam Pract. 2023 Jul;72(6):260-263. doi: 10.12788/jfp.0642.ABSTRACTThe CDC recently issued guidance on screening for hepatitis B infection. Here's a look at how (and why) these recommendations differ from those of the USPSTF.PMID:37549402 | DOI:10.12788/jfp.0642
Source: The Journal of Family Practice - August 7, 2023 Category: Practice Management Authors: Doug Campos-Outcalt Source Type: research
The emerging role of miRNA-122 in infectious diseases: Mechanisms and potential biomarkers
Pathol Res Pract. 2023 Jul 27;249:154725. doi: 10.1016/j.prp.2023.154725. Online ahead of print.ABSTRACTmicroRNAs (miRNAs) are small, non-coding RNA molecules that play crucial regulatory roles in numerous cellular processes. Recent investigations have highlighted the significant involvement of miRNA-122 (miR-122) in the pathogenesis of infectious diseases caused by diverse pathogens, encompassing viral, bacterial, and parasitic infections. In the context of viral infections, miR-122 exerts regulatory control over viral replication by binding to the viral genome and modulating the host's antiviral response. For instance, i...
Source: Pathology, Research and Practice - August 6, 2023 Category: Pathology Authors: Rasoul Mirzaei Sajad Karampoor Nadezhda Lenoktovna Korotkova Source Type: research
Novel anti ‑hepatitis B virus flavonoids sakuranetin and velutin from < em > Rhus retinorrhoea < /em >
In conclusion, the present study was the first to demonstrate the anti‑HBV therapeutic activities of SEK and VEL isolated from R. retinorrhoea.PMID:37539729 | DOI:10.3892/mmr.2023.13063
Source: Molecular Medicine - August 4, 2023 Category: Molecular Biology Authors: Sarfaraz Ahmed Mohammad K Parvez Mohammed S Al-Dosari Mazin A S Abdelwahid Tawfeq A Alhowiriny Adnan J Al-Rehaily Source Type: research
Recent Progress and Challenges in the Development of Edible Vaccines Produced by Genetically Modified Plants
This article includes important uses, production, host plants, benefits, drawbacks, mechanism of action, and many regulatory difficulties related to edible vaccines. In this article, we have discussed the most recent developments and successes with edible and intradermal vaccines in terms of the system used for immunogen production, the molecular properties of these vaccines, and their ability to generate a protective systemic and mucosal response.PMID:37537938 | DOI:10.2174/1389203724666230804095716
Source: Current Protein and Peptide Science - August 4, 2023 Category: Biochemistry Authors: Smita Singh Pranjal Kumar Singh Kapil Sachan Sakshi Garg Alok Nath Sharma Source Type: research
Novel anti ‑hepatitis B virus flavonoids sakuranetin and velutin from < em > Rhus retinorrhoea < /em >
In conclusion, the present study was the first to demonstrate the anti‑HBV therapeutic activities of SEK and VEL isolated from R. retinorrhoea.PMID:37539729 | DOI:10.3892/mmr.2023.13063
Source: Molecular Medicine - August 4, 2023 Category: Molecular Biology Authors: Sarfaraz Ahmed Mohammad K Parvez Mohammed S Al-Dosari Mazin A S Abdelwahid Tawfeq A Alhowiriny Adnan J Al-Rehaily Source Type: research
Recent Progress and Challenges in the Development of Edible Vaccines Produced by Genetically Modified Plants
This article includes important uses, production, host plants, benefits, drawbacks, mechanism of action, and many regulatory difficulties related to edible vaccines. In this article, we have discussed the most recent developments and successes with edible and intradermal vaccines in terms of the system used for immunogen production, the molecular properties of these vaccines, and their ability to generate a protective systemic and mucosal response.PMID:37537938 | DOI:10.2174/1389203724666230804095716
Source: Current Protein and Peptide Science - August 4, 2023 Category: Biochemistry Authors: Smita Singh Pranjal Kumar Singh Kapil Sachan Sakshi Garg Alok Nath Sharma Source Type: research
Modeling the impact of vaccination for the immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030
Vaccine. 2023 Aug 1:S0264-410X(23)00854-X. doi: 10.1016/j.vaccine.2023.07.033. Online ahead of print.ABSTRACTBACKGROUND: The Immunization Agenda 2030 (IA2030) Impact Goal 1.1. aims to reduce the number of future deaths averted through immunization in the next decade. To estimate the potential impact of the aspirational coverage targets for IA2030, we developed an analytical framework and estimated the number of deaths averted due to an ambitious vaccination coverage scenario from 2021 to 2030 in 194 countries.METHOD: A demographic model was used to determine annual age-specific mortality estimates associated with vaccine c...
Source: Vaccine - August 3, 2023 Category: Allergy & Immunology Authors: Austin Carter William Msemburi So Yoon Sim Katy A M Gaythorpe Philipp Lambach Ann Lindstrand Raymond Hutubessy Source Type: research
